UK-based Pharmanovia has appointed Béchir Ben Hadj Yahia as global head of medical affairs, as it expands its presence in ...
Indian pharma major Lupin has launched Formoflo-G MDI, a fixed-dose triple-combination metered-dose inhaler (MDI) for ...
Some three-quarters of senior biopharma executives expect appetite for partnering and M&A to rise over the next 12 months, and none expect it to fall, according to the inaugural Biopharma C-Suite ...
Dutch life sciences venture capital firm Forbion has raised 2.3 billion euros ($2.6 billion) across two new funds, its ...
French hearing loss specialist Sensorion today announced the appointment of Louis “Lou” Arcudi III as chief financial officer ...
China uses two major mechanisms to negotiate medicine prices, offering manufacturers a route to substantial demand in exchange for terms acceptable to public purchasers and insurers. One organizes ...
Cancer drug developers seeking approval in several countries can bring regulators together through Project Orbis, allowing agencies to discuss the same evidence while retaining responsibility for ...
US biotech Matchpoint Therapeutics today announced the successful closing of a $150 million Series B financing.
US biotech company ArriVent BioPharma (Nasdaq: AVBP) is reviewing the development path for firmonertinib after its Phase III ...
Julian Beach, Medicines and Healthcare products Regulatory Agency (MHRA) interim executive director of healthcare, quality ...
China-based Asieris Pharmaceuticals, which is focused on developing and commercializing innovative therapies for the ...
US drug delivery company Halozyme Therapeutics has said that the specialized Dutch patent court in The Hague has found Merck & Co to be infringing one of its MDASE patents, EP 2,797,622, and has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results